[HTML][HTML] Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - europepmc.org
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could
Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? - Abstract - Europe …
Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? - Abstract - Europe …
Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?
AFG Cicero, F Fogacci, AP Stoian, M Vrablik… - 2021 - cabidigitallibrary.org
Abstract Purpose of Review: The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
[HTML][HTML] Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid …
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - ncbi.nlm.nih.gov
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could
Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? - PMC Back to Top …
Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? - PMC Back to Top …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
AFG Cicero, F Fogacci, A Stoian, M Vrablik… - CURRENT …, 2021 - cris.unibo.it
Purpose of review: The aim of this review is to summarize the available clinical efficacy and
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low‑Risk Individuals with Non‑optimal Lipid Levels?
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - publicum.umed.lodz.pl
Purpose of review: The aim of this review is to summarize the available clinical efficacy and
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose of review The aim of this review is to summarize the available clinical efficacy and
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - squ.elsevierpure.com
PURPOSE OF REVIEW: The aim of this review is to summarize the available clinical efficacy
and safety data related to the most studied and used lipid-lowering nutraceuticals. RECENT …
and safety data related to the most studied and used lipid-lowering nutraceuticals. RECENT …
[PDF][PDF] Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low‑Risk Individuals with Non‑optimal Lipid …
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - researchgate.net
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low‑Risk Individuals with Non‑optimal Lipid Levels?
AFG Cicero, F Fogacci, AP Stoian… - Current …, 2021 - publicum.umed.lodz.pl
Purpose of review: The aim of this review is to summarize the available clinical efficacy and
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …
safety data related to the most studied and used lipid-lowering nutraceuticals. Recent …